These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 32110837

  • 1. Efficacy of albumin and compounded plasma for plasma exchange in acquired thrombotic thrombocytopenic purpura.
    Hou R, Tian W, Qiao R, Zhang J.
    J Clin Apher; 2020 Jun; 35(3):154-162. PubMed ID: 32110837
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of cryoprecipitate-poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: a single center retrospective evaluation.
    Stefanello B, De Paula EV, Andrade Orsi F, Comenalli Marques JF, Gasparotto Roveri E, Pereira Colella M, Castro Ozelo M, Maria Annichino-Bizzacchi J, Addas-Carvalho M.
    J Clin Apher; 2014 Dec; 29(6):311-5. PubMed ID: 24890787
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study.
    Korkmaz S, Keklik M, Sivgin S, Yildirim R, Tombak A, Kaya ME, Acik DY, Esen R, Hacioglu SK, Sencan M, Kiki I, Tiftik EN, Kuku I, Okan V, Yilmaz M, Demir C, Sari I, Altuntas F, Unal A, Ilhan O.
    Transfus Apher Sci; 2013 Jun; 48(3):353-8. PubMed ID: 23602056
    [Abstract] [Full Text] [Related]

  • 4. Combination of Fresh Frozen Plasma and Cryosupernatant Plasma for Therapeutic Plasma Exchange in Thrombotic Thrombocytopenic Purpura: A Single Institution Experience.
    Lin Q, Fan L, Huang H, Zeng F, Fu D, Wei S.
    Biomed Res Int; 2019 Jun; 2019():1756109. PubMed ID: 30834255
    [Abstract] [Full Text] [Related]

  • 5. Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Members of the Canadian Apheresis Group.
    Rock G, Shumak KH, Sutton DM, Buskard NA, Nair RC.
    Br J Haematol; 1996 Aug; 94(2):383-6. PubMed ID: 8759902
    [Abstract] [Full Text] [Related]

  • 6. Methylene blue-photoinactivated plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura.
    Alvarez-Larrán A, Del Río J, Ramírez C, Albo C, Peña F, Campos A, Cid J, Muncunill J, Sastre JL, Sanz C, Pereira A.
    Vox Sang; 2004 May; 86(4):246-51. PubMed ID: 15144529
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study.
    Altuntas F, Aydogdu I, Kabukcu S, Kocyigit I, Cikim K, Sari I, Erkut MA, Eser B, Ozturk A, Kaya E, Cetin M, Keskin A, Unal A.
    Transfus Apher Sci; 2007 Feb; 36(1):57-67. PubMed ID: 17240195
    [Abstract] [Full Text] [Related]

  • 8. Therapeutical plasma exchange for thrombotic thrombocytopenic purpura in the emergency department: A single center experience.
    Li XM, Mo XY, Huang GQ, Zhang FJ.
    Am J Emerg Med; 2021 Aug; 46():556-559. PubMed ID: 33214018
    [Abstract] [Full Text] [Related]

  • 9. Treatment of thrombotic thrombocytopenic purpura with the cryosupernatant fraction of plasma: a case report and review of the literature.
    Ellis J, Theodossiou C, Schwarzenberger P.
    Am J Med Sci; 1999 Sep; 318(3):190-3. PubMed ID: 10487410
    [Abstract] [Full Text] [Related]

  • 10. Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP).
    Zeigler ZR, Shadduck RK, Gryn JF, Rintels PB, George JN, Besa EC, Bodensteiner D, Silver B, Kramer RE, North American TTP Group.
    J Clin Apher; 2001 Sep; 16(1):19-22. PubMed ID: 11309826
    [Abstract] [Full Text] [Related]

  • 11. Is Cryoprecipitate-Reduced Plasma an Efficacious Replacement Fluid for Therapeutic Plasma Exchange for Patients with Thrombotic Microangiopathy? A Single-Center Retrospective Experience.
    Kim HJ, Yang JJ, Kim H, Hwang SH, Oh HB, Chung Y, Ko DH.
    Lab Med; 2022 May 05; 53(3):266-272. PubMed ID: 34791373
    [Abstract] [Full Text] [Related]

  • 12. The use of 50% albumin/plasma replacement fluid in therapeutic plasma exchange for thrombotic thrombocytopenic purpura.
    O'Brien KL, Price TH, Howell C, Delaney M.
    J Clin Apher; 2013 Dec 05; 28(6):416-21. PubMed ID: 23857424
    [Abstract] [Full Text] [Related]

  • 13. A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura.
    Mintz PD, Neff A, MacKenzie M, Goodnough LT, Hillyer C, Kessler C, McCrae K, Menitove JE, Skikne BS, Damon L, Lopez-Plaza I, Rouault C, Crookston KP, Benjamin RJ, George J, Lin JS, Corash L, Conlan MG.
    Transfusion; 2006 Oct 05; 46(10):1693-704. PubMed ID: 17002625
    [Abstract] [Full Text] [Related]

  • 14. Complications of therapeutic plasma exchange: a prospective study of 1,727 procedures.
    Shemin D, Briggs D, Greenan M.
    J Clin Apher; 2007 Oct 05; 22(5):270-6. PubMed ID: 17722046
    [Abstract] [Full Text] [Related]

  • 15. How we approach an acquired thrombotic thrombocytopenic purpura patient.
    Raval JS, Mazepa MA, Brecher ME, Park YA.
    Transfusion; 2014 Oct 05; 54(10):2375-82. PubMed ID: 25070750
    [Abstract] [Full Text] [Related]

  • 16. Incidence of allergic reactions with fresh frozen plasma or cryo-supernatant plasma in the treatment of thrombotic thrombocytopenic purpura.
    Reutter JC, Sanders KF, Brecher ME, Jones HG, Bandarenko N.
    J Clin Apher; 2001 Oct 05; 16(3):134-8. PubMed ID: 11746540
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of lymphoplasmapheresis compared with therapeutic plasma exchange for thrombotic thrombocytopenic purpura: a retrospective evaluation.
    Zhang Z, Yuan X, Jiang Y, Li N, Li B.
    Hematology; 2022 Dec 05; 27(1):167-172. PubMed ID: 35068383
    [Abstract] [Full Text] [Related]

  • 18. High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome.
    Coppo P, Bussel A, Charrier S, Adrie C, Galicier L, Boulanger E, Veyradier A, Leblanc T, Alberti C, Azoulay E, Le Gall JR, Schlemmer B.
    Medicine (Baltimore); 2003 Jan 05; 82(1):27-38. PubMed ID: 12544708
    [Abstract] [Full Text] [Related]

  • 19. Twice-daily therapeutical plasma exchange-based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.
    Soucemarianadin M, Benhamou Y, Delmas Y, Pichereau C, Maury E, Pène F, Halimi JM, Presne C, Thouret JM, Veyradier A, Coppo P.
    Eur J Haematol; 2016 Aug 05; 97(2):183-91. PubMed ID: 26608617
    [Abstract] [Full Text] [Related]

  • 20. Nine years of cascade filtration for thrombotic thrombocytopenic purpura.
    Valbonesi M, Giannini G.
    Ther Apher Dial; 2004 Apr 05; 8(2):87-92. PubMed ID: 15255122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.